The Pillars of Power: Why Big Pharma's Future Rides on Chinese Science In recent months, the US government has sounded alarm bells about China's growing dominance in clinical drug development and supply chain management.
But what does this shift mean for the pharma industry, and more importantly, for patients? According to Dr.
Nathan Goodyear, an integrative medicine physician with extensive experience in China, the scale of the shift is nothing short of striking.